Close Menu
  • News
  • Home
  • In Profile
  • Finance
  • Legal
  • Technology
  • Events
  • Features
  • Wellbeing & Mental Health
  • Marketing
  • HR & Recruitment
  • About
  • Advertise
  • Events Calendar
  • Business Wall
  • Subscribe
  • Contact
  • 0843 289 4634
X (Twitter) LinkedIn YouTube
Trending
  • New Venture Aims To Help Propel Growth For Start-Ups
  • Building community, one cause at a time
  • How to build a £1 million pension and ISA portfolio
  • 5 Reasons Why Every Office Should Include Flexible Spaces to Work and Their Key Benefits
  • Pension reforms risk higher prices, fewer jobs and slower growth, FSB warns
  • Building Trust in AI Through a Decision-Centric Approach in Manufacturing
  • In Profile: Michael Stausholm, founder and CEO of SproutWorld
  • A beginner’s guide to growth shares (and why they’re so popular right now)
X (Twitter) LinkedIn YouTube
SME Today
  • About
  • Advertise
  • Events Calendar
  • Business Wall
  • Subscribe
  • Contact
  • 0843 289 4634
  • News
  • Home
  • In Profile
  • Finance
  • Legal
  • Technology
  • Events
  • Features
  • Wellbeing
  • Marketing
  • HR & Recruitment
SME Today
  • About
  • Advertise
  • Events Calendar
  • Business Wall
  • Subscribe
  • Contact
  • 0843 289 4634
  • Twitter
  • LinkedIn
  • YouTube
  • RSS
You are at:Home»News»Additional 40 million Valneva vaccine doses secured by UK
Antigen quantification at Valneva laboratories in Vienna Austria, on Thursday, 06. August 2020. Photo: Akos Stiller

Additional 40 million Valneva vaccine doses secured by UK

0
Posted By sme-admin on February 2, 2021 News

The UK Government has today, Monday 1st February, signed a deal for a further 40 million doses of Valneva’s promising vaccine candidate. The deal takes the total number of Valneva vaccines to 100 million and means that the UK has now secured early access to over 400 million total doses of vaccines for 2021 and 2022.

The 100 million doses of Valneva vaccine will be manufactured at Valneva’s site in West Lothian, Scotland, supporting 100 highly-skilled jobs.

The decision to purchase 40 million extra doses is based on the UK’s strategy to take a wide approach, using different technologies and viral targets to ensure the UK has the best chance of securing access to successful vaccines as quickly as possible. It will also give the UK future flexibility should we need to revaccinate any of the population.

The UK Government has invested a multi-million sum in Valneva’s manufacturing facility in West Lothian, which began manufacturing vaccine doses last week and is already raising Scotland’s profile in the international fight against Covid-19.

Valneva’s coronavirus vaccine candidate is currently in phase I/II trials and will still need to meet the necessary safety and effectiveness standards and receive regulatory approval from the UK Medicines and Healthcare products Regulatory Agency (MHRA) before it is rolled out at the end of the year.

However, if it is approved, it will mean that the UK can roll vaccinations out across the country even quicker.

Business Secretary Kwasi Kwarteng commented, “This latest deal is yet another weapon in our national arsenal against this terrible disease, and will ensure we have sufficient supplies to protect the British public in 2021 and beyond. Backed with major investment from the UK Government, Valneva’s site in Scotland will be a vaccine production powerhouse, working flat out to ensure we can quickly deploy jabs across the UK if their candidate is approved, while supporting top quality, local jobs.”

Vaccines Minister Nadhim Zahawi said, “This deal provides a further boost to the UK’s already-strong vaccine portfolio, and I am enormously proud of all the work which has gone in to securing a vaccine for the UK as soon as possible. If approved, Valneva’s vaccine will not only help tackle Covid-19 here in the UK, but aid our mission to ensure there is a fair supply of vaccines across the globe.”

Valneva’s Livingston site will have the capacity to produce up to 250 million doses annually for shipment across the UK and around the world. If it is approved, 60 million doses could start to be delivered to the UK by the second half of 2021, with the remaining 40 million being delivered in 2022.

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Related Posts

New Venture Aims To Help Propel Growth For Start-Ups

Pension reforms risk higher prices, fewer jobs and slower growth, FSB warns

£20k grant for female-founded SME up for grabs

Comments are closed.

Follow SME Today on Linkedin and share all the topics you find interesting
Verify your identity for Companies House

The Newsletter

Join our mailing list for the best SME stories, handpicked and delivered direct to your inbox every two weeks!

Sign Up
Events Calendar
    • Marketing
    July 7, 2025

    Bold Business Marketing Specialist Speaks In Swindon This Week

    July 4, 2025

    How Generative AI is Giving SMEs a Marketing Edge

    • Finance
    July 10, 2025

    How to build a £1 million pension and ISA portfolio

    July 10, 2025

    Pension reforms risk higher prices, fewer jobs and slower growth, FSB warns

    • Health & Safety
    July 1, 2025

    Temperatures Soaring: Is Your Workplace Becoming Unsafe?

    January 29, 2025

    UK takeaways guilty of shocking hygiene failures:

    • Events
    July 4, 2025

    £20k grant for female-founded SME up for grabs

    July 2, 2025

    As Seen on BBC Panorama – Brad Burton to Headline The South West Expo in Swindon

    • Community
    July 11, 2025

    Building community, one cause at a time

    June 23, 2025

    Celebrating One Year In Fairford Supporting The Community

    • Food & Drink
    June 23, 2025

    England Cricket Captain, Ben Stokes OBE, takes a stake in Spencer Matthews’ alcohol-free spirits brand, CleanCo

    June 16, 2025

    Hospitality industry risks collapse

    • Books
    April 24, 2025

    Values-Driven Professionalism: A Path to Client Loyalty

    December 2, 2024

    Banish the banshee boss: how to lead without fear – addressing the issue of fear-based management and how NOT to be this manager

    About

    SME Today is published by the same team who deliver The Great British Expos’. We have been organising various corporate events for the last 10 years, with a strong track record of producing well managed and attended business events across the UK.

    Join Our Mailing List

    Receive the latest news and updates from SMEToday.
    Read our Latest Newsletter:


    Sign Up
    X (Twitter) YouTube LinkedIn
    Most Recent Posts
    July 11, 2025

    New Venture Aims To Help Propel Growth For Start-Ups

    July 11, 2025

    Building community, one cause at a time

    July 10, 2025

    How to build a £1 million pension and ISA portfolio

    July 10, 2025

    5 Reasons Why Every Office Should Include Flexible Spaces to Work and Their Key Benefits

    July 10, 2025

    Pension reforms risk higher prices, fewer jobs and slower growth, FSB warns

    Categories
    • Books
    • Community & Charity
    • Education and Training
    • Environment
    • Events
    • Features
    • Finance
    • Food and Drink
    • Health & Safety
    • HR & Recruitment
    • In Profile
    • Legal
    • Marketing
    • News
    • Property & Development
    • Sponsored Content
    • Technology
    • Transport & Tourism
    • Wellbeing & Mental Health

    Copyright © 2020 SME Today.

    • ABOUT SME TODAY: THE GO TO RESOURCE FOR UK BUSINESSES
    • Privacy
    • Contact
    Copyright © 2025 SME Today.
    • ABOUT SME TODAY: THE GO TO RESOURCE FOR UK BUSINESSES
    • Privacy
    • Contact

    Type above and press Enter to search. Press Esc to cancel.